American Heart News - Heart News
FEBRUARY 27, 2024
Research Highlights Closer proximity to and a higher number of ready-to-eat food outlets — particularly pubs, bars and fast-food restaurants — may be associated with a greater risk of developing heart failure, according to a study of half a million.
HCPLive
FEBRUARY 27, 2024
Minerva Neurosciences announced the receipt of a Complete Response Letter for roluperidone in treatment of negative symptoms in patients with schizophrenia on February 27, 2024 despite clinical trial data indicating improved Negative Symptom Factor Scores and Personal and Social Performance scale scores.
Med Page Today
FEBRUARY 27, 2024
(MedPage Today) -- Patients with type 2 diabetes had better glycemic control and higher rates of diabetes remission over the long term with bariatric surgery compared with lifestyle and medical management in the pre-GLP-1 receptor agonist era.
Cardiovascular Diabetology
FEBRUARY 27, 2024
Non-alcoholic fatty liver disease (NAFLD), identified by the Fatty Liver Index (FLI), is associated with increased mortality and cardiovascular (CV) outcomes. Whether this also applies to type 1 diabetes (T1D).
Med Page Today
FEBRUARY 27, 2024
(MedPage Today) -- A novel class of antithrombotic medication, the factor XIa inhibitors, has had a rocky start but is powering through phase III trials, which are now underway. MedPage Today sat down to discuss the novel agents with Graeme Hankey.
DAIC
FEBRUARY 27, 2024
milla1cf Tue, 02/27/2024 - 17:29 February 27, 2024 — Aria CV, Inc , a developer of medical devices treating pulmonary hypertension, today announced the first patient was implanted with the Gen 2 Aria CV Pulmonary Hypertension System as part of the ASPIRE PH clinical trial at Ascension St. Vincent Cardiovascular Research Institute in Indianapolis, Indiana.
Nature Reviews - Cardiology
FEBRUARY 27, 2024
Nature Reviews Cardiology, Published online: 28 February 2024; doi:10.1038/s41569-024-01004-2 Atrial fibrillation is the most common sustained arrhythmia and imposes a substantial burden on patients and health-care providers. Clinical evidence suggests that antiarrhythmic therapy to restore and maintain sinus rhythm (rhythm control) can reduce adverse cardiovascular outcomes in patients with new-onset atrial fibrillation.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Dr. Paddy Barrett
FEBRUARY 27, 2024
Most people only start to worry about cardiovascular risk later in life. This is a bad idea. Here’s why. When you look at the risk of having a heart attack, it is true that the older you are, the greater the odds of having a heart attack 1. So far, so good. But this graph is very misleading. While only 1-2% of those having a heart attack are less than 65 years of age, 1-2% of this very large number means a LOT of heart attacks.
ECG Cases
FEBRUARY 27, 2024
Anand Swaminathan on an update on the appropriate selection of induction agents. Hans Rosenberg on when to use gabapentinoids for pain control in the ED. Katie Lin on pearls for neuroprotective intubation. Nour Khatib and Hamza Jalal on an approach to paresthesias in the ED. Eric Wortmann on preventing burnout in emergency medicine. Please support EM Cases with a donation [link] The post EM Quick Hits 55 – Induction Agents, Gabapentinoids, Neuroprotective Intubation, Approach to Paresthesi
Open Heart
FEBRUARY 27, 2024
Objectives The clinical outcomes of transcatheter aortic valve replacement (TAVR) in patients with aortic stenosis (AS) and concomitant active cancer remain insufficiently explored. This study aimed to assess the midterm outcomes of TAVR in patients diagnosed with AS and active cancer. Methods Data from the OCEAN-TAVI, a prospective Japanese registry of TAVR procedures, was analysed to compare prognoses and clinical outcomes in patients with and without active cancer at the time of TAVR.
HCPLive
FEBRUARY 27, 2024
The presence of sinusitis is linked to a 40% heightened risk of a diagnosis of rheumatic disease, particularly in the 5 to 10 years before disease onset.
Journal of the American Heart Association
FEBRUARY 27, 2024
Journal of the American Heart Association, Ahead of Print. BackgroundSedentary behavior is a recognized mortality risk factor. The novel and validated convolutional neural network hip accelerometer posture algorithm highly accurately classifies sitting and postural changes compared with accelerometer count cut points. We examined the prospective associations of convolutional neural network hip accelerometer posture–classified total sitting time and mean sitting bout duration with all‐cause and c
HCPLive
FEBRUARY 27, 2024
Brassica Pharma Pvt. Ltd. is voluntarily recalling eye ointment products with expiration dates from February 2024 to September 2025.
Journal of the American Heart Association
FEBRUARY 27, 2024
Journal of the American Heart Association, Ahead of Print. BackgroundIndividual pregnancy complications are associated with increased maternal risk of cardiovascular disease. We assessed the link between a woman's total pregnancy history at 40 years of age and her relative risk of dying from atherosclerotic cardiovascular disease (ASCVD).Methods and ResultsThis population‐based prospective study combined several Norwegian registries covering the period 1967 to 2020.
HCPLive
FEBRUARY 27, 2024
Deepak Bhatt, MD, MPH, looks ahead to discuss what he is most excited about from the upcoming late-breaking clinical trials sessions at the American College of Cardiology 2024 annual meeting
Becker's Hospital Review - Cardiology
FEBRUARY 27, 2024
Lars Svensson, MD, PhD, was on vacation in 1967 when he and his father heard about the first person-to-person heart transplant, performed by South African surgeon Christiaan Barnard.
Journal of the American Heart Association
FEBRUARY 27, 2024
Journal of the American Heart Association, Ahead of Print. BackgroundCardiovascular disease remains an important comorbidity in patients with rheumatoid arthritis (RA), but traditional models do not accurately predict cardiovascular risk in patients with RA. The addition of biomarkers could improve prediction.Methods and ResultsThe TARGET (Treatments Against RA and Effect on FDG PET/CT) trial assessed whether different treatment strategies in RA differentially impact cardiovascular risk as measu
HCPLive
FEBRUARY 27, 2024
In this Q&A discussion, Bhatt discusses the recent news of dupilumab’s supplemental Biologics License Application for COPD patients with type 2 inflammation, as well as its significance.
Science Daily - Heart Disease
FEBRUARY 27, 2024
Findings of a review of data from three clinical trials challenge current best practice for use of the drug for primary prevention of heart disease or stroke -- otherwise known as atherosclerotic cardiovascular disease. The analysis of data from three international clinical trials points to a need for further evidence on best practice among adults already taking aspirin for cardiovascular disease prevention.
Cardiovascular Diabetology
FEBRUARY 27, 2024
Insulin resistance (IR) is involved in the pathophysiological processes of arrhythmias. Increasing evidence suggests triglyceride and glucose (TyG) index, metabolic score for insulin resistance (METS-IR), trig.
Frontiers in Cardiovascular Medicine
FEBRUARY 27, 2024
Background Chronic Kidney Disease (CKD) stands as a formidable health challenge, recognized not only for its growing prevalence but also for its association with elevated mortality rates. Emerging evidence suggests that CKD is inherently linked to inflammatory processes, marking it as an inflammatory disorder. In this landscape, the systemic inflammatory response index (SIRI) emerges as a novel inflammation marker, yet to be applied for assessing the risk of mortality in CKD patients.
HCPLive
FEBRUARY 27, 2024
Results suggest a high prevalence of fatty liver in adults with chronic HCV, which was significantly associated with central obesity, elevated blood pressure, and metabolic syndrome.
Frontiers in Cardiovascular Medicine
FEBRUARY 27, 2024
Objective This study aims to review the application of deep learning techniques in the imaging diagnosis and treatment of aortic aneurysm (AA), focusing on screening, diagnosis, lesion segmentation, surgical assistance, and prognosis prediction. Methods A comprehensive literature review was conducted, analyzing studies that utilized deep learning models such as Convolutional Neural Networks (CNNs) in various aspects of AA management.
American College of Cardiology
FEBRUARY 27, 2024
The goal of the KARDIA-1 trial was to evaluate zilebesiran compared with placebo among patients with hypertension. Zilebesiran is a subcutaneous injectable that targets hepatic angiotensinogen (AGT) synthesis by RNA interference.
Frontiers in Cardiovascular Medicine
FEBRUARY 27, 2024
Background Primary cardiac lymphoma is an extremely rare malignant lymphoma, with clinical manifestations related to its location. We reported the diagnosis and treatment of primary cardiac lymphoma in a patient presented with atrioventricular block. Case presentation A 64 year-old man was admitted to our hospital because of symptoms of a tired heart and shortness of breath.
HCPLive
FEBRUARY 27, 2024
Hosts break down their favorite sessions at the upcoming 17th International Conference on Advanced Technologies and Treatments for Diabetes.
Frontiers in Cardiovascular Medicine
FEBRUARY 27, 2024
Background Valvular heart disease is a major health concern worldwide. The effective management of patients undergoing valve replacement determines their prognosis. Bibliometric analysis of studies on managing patients with artificial heart valves has not been previously performed. Methods This study analyzed 2,771 publications related to patient management after valve replacement published in the Web of Science Core Collection database between January 1, 2013, and December 31, 2022.
American College of Cardiology
FEBRUARY 27, 2024
As interest in training for critical care cardiology (CCC) continues to rise, a recent study found there is significant heterogeneity in current standardized CCC training paradigms for meeting training competencies and board certifications, reinforcing the unmet need to define competencies in the field, according to a study published Feb. 12 in JACC: Advances.
HCPLive
FEBRUARY 27, 2024
Viaskin milk patch shows promise in cow’s milk allergy, particularly in children aged 2-11 with 300 μg dose, though the other doses examined failed to prove significant benefit.
Cardiovascular Diabetology
FEBRUARY 27, 2024
The Stress hyperglycemia ratio (SHR) is a novel marker reflecting the true acute hyperglycemia status and is associated with clinical adverse events. The relationship between SHR and mortality in patients with.
HCPLive
FEBRUARY 27, 2024
This publication was developed independently by MJH Life Sciences Global Medical Affairs. Support for the thought leaders meeting and the publication was provided by Arcutis Biotherapeutics, Inc; The Bristol Myers Squibb Company; Janssen Global Services, LLC; and UCB, Inc.
Cardiovascular Diabetology
FEBRUARY 27, 2024
Studies on the relationship between insulin resistance (IR) surrogates and long-term all-cause mortality in patients with coronary heart disease (CHD) and hypertension are lacking. This study aimed to explore.
HCPLive
FEBRUARY 27, 2024
This publication was developed independently by MJH Life Sciences Global Medical Affairs. Support for the thought leaders meeting and the publication was provided by Arcutis Biotherapeutics, Inc; The Bristol Myers Squibb Company; Janssen Global Services, LLC; and UCB, Inc.
Med Page Today
FEBRUARY 27, 2024
(MedPage Today) -- Receipt of Supplemental Nutrition Assistance Program benefits was associated with better adherence to antihypertensive medications. (JAMA Network Open) A new standard for chest protector equipment is intended to reduce the risk.
HCPLive
FEBRUARY 27, 2024
This publication was developed independently by MJH Life Sciences Global Medical Affairs. Support for the thought leaders meeting and the publication was provided by Arcutis Biotherapeutics, Inc; The Bristol Myers Squibb Company; Janssen Global Services, LLC; and UCB, Inc.
JAMA Cardiology
FEBRUARY 27, 2024
This prespecified secondary analysis of the Diagnostic Imaging Strategies for Patients With Stable Chest Pain and Intermediate Risk of Coronary Artery Disease (DISCHARGE) randomized clinical trial investigates the association of age with clinical outcomes after computed tomography and coronary angiography in stable chest pain.
HCPLive
FEBRUARY 27, 2024
This publication was developed independently by MJH Life Sciences Global Medical Affairs. Support for the thought leaders meeting and the publication was provided by Arcutis Biotherapeutics, Inc; The Bristol Myers Squibb Company; Janssen Global Services, LLC; and UCB, Inc.
Expert insights. Personalized for you.
139 
Let's personalize your content